| Zafar Iqbal, MD | |
|
201 Lyons Ave, Newark Beth Israel Medical Center, Newark, NJ 07112-2027 | |
| (973) 926-7000 | |
| Not Available |
| Full Name | Zafar Iqbal |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 22 Years |
| Location | 201 Lyons Ave, Newark, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053571703 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 25MA08658900 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Musc Health Lancaster Medical Center | Lancaster, SC | Hospital |
| Piedmont Medical Center | Rock hill, SC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Carolina Heart Specialists Llc | 0648361196 | 8 |
News Archive
Acumed and Arthrex are pleased to announce that they have reached a mutually acceptable resolution of their patent infringement dispute involving Acumed's U.S. Patent Nos. 6,984,235 and 8,070,786 and Arthrex's Compression FT bone screws.
Cytotoxin-associated gene A protein (CagA) from type I H.pylori has been proved by epidemiological and experimental studies to be closely associated with the H.pylori induced gastric diseases, especially gastric cancer.
The August 8 visit of a U.S. delegation to the drought-stricken Horn of Africa "was important in terms of shedding light on the important efforts that are under way and the importance of continued support from the international community," Assistant Secretary of State for Population, Refugees and Migration Eric Schwartz said on Tuesday during a briefing on the trip, IIP Digital reports.
DiagnoCure Inc. (TSX: CUR) announced that Gen-Probe, Inc. (NASDAQ: GPRO), its partner for the development and commercialization of the PCA3 prostate cancer test, has confirmed today the beginning of a U.S. clinical study intended to secure U.S. regulatory approval of the PROGENSA(R) PCA3 assay, a new molecular test that may help determine the need for a repeat prostate biopsy.
AstraZeneca announced today that the US Food and Drug Administration (FDA) has acknowledged receipt of the company's reply to the Complete Response Letter (CRL) for the ticagrelor New Drug Application (NDA).
› Verified 5 days ago
| Entity Name | Carolina Heart Specialists Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881802841 PECOS PAC ID: 0648361196 Enrollment ID: O20070813000322 |
News Archive
Acumed and Arthrex are pleased to announce that they have reached a mutually acceptable resolution of their patent infringement dispute involving Acumed's U.S. Patent Nos. 6,984,235 and 8,070,786 and Arthrex's Compression FT bone screws.
Cytotoxin-associated gene A protein (CagA) from type I H.pylori has been proved by epidemiological and experimental studies to be closely associated with the H.pylori induced gastric diseases, especially gastric cancer.
The August 8 visit of a U.S. delegation to the drought-stricken Horn of Africa "was important in terms of shedding light on the important efforts that are under way and the importance of continued support from the international community," Assistant Secretary of State for Population, Refugees and Migration Eric Schwartz said on Tuesday during a briefing on the trip, IIP Digital reports.
DiagnoCure Inc. (TSX: CUR) announced that Gen-Probe, Inc. (NASDAQ: GPRO), its partner for the development and commercialization of the PCA3 prostate cancer test, has confirmed today the beginning of a U.S. clinical study intended to secure U.S. regulatory approval of the PROGENSA(R) PCA3 assay, a new molecular test that may help determine the need for a repeat prostate biopsy.
AstraZeneca announced today that the US Food and Drug Administration (FDA) has acknowledged receipt of the company's reply to the Complete Response Letter (CRL) for the ticagrelor New Drug Application (NDA).
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Zafar Iqbal, MD 18 Summit St, Apt # 120, West Orange, NJ 07052-1505 Ph: (267) 226-6702 | Zafar Iqbal, MD 201 Lyons Ave, Newark Beth Israel Medical Center, Newark, NJ 07112-2027 Ph: (973) 926-7000 |
News Archive
Acumed and Arthrex are pleased to announce that they have reached a mutually acceptable resolution of their patent infringement dispute involving Acumed's U.S. Patent Nos. 6,984,235 and 8,070,786 and Arthrex's Compression FT bone screws.
Cytotoxin-associated gene A protein (CagA) from type I H.pylori has been proved by epidemiological and experimental studies to be closely associated with the H.pylori induced gastric diseases, especially gastric cancer.
The August 8 visit of a U.S. delegation to the drought-stricken Horn of Africa "was important in terms of shedding light on the important efforts that are under way and the importance of continued support from the international community," Assistant Secretary of State for Population, Refugees and Migration Eric Schwartz said on Tuesday during a briefing on the trip, IIP Digital reports.
DiagnoCure Inc. (TSX: CUR) announced that Gen-Probe, Inc. (NASDAQ: GPRO), its partner for the development and commercialization of the PCA3 prostate cancer test, has confirmed today the beginning of a U.S. clinical study intended to secure U.S. regulatory approval of the PROGENSA(R) PCA3 assay, a new molecular test that may help determine the need for a repeat prostate biopsy.
AstraZeneca announced today that the US Food and Drug Administration (FDA) has acknowledged receipt of the company's reply to the Complete Response Letter (CRL) for the ticagrelor New Drug Application (NDA).
› Verified 5 days ago
Dr. Xiaoning Joanie Zhu, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 741 Broadway, Newark, NJ 07104 Phone: 973-481-1300 | |
Lissette Maria Cespedes, M.D. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 185 S Orange Ave, Msb I588, Newark, NJ 07103 Phone: 973-972-3479 | |
Dr. Pankaja Achar, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 194 Clinton Ave Fl 2, Newark, NJ 07108 Phone: 973-273-1515 Fax: 973-230-0883 | |
Marc H. Lavietes, M.D. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 90 Bergen St, Doc 4500, Newark, NJ 07103 Phone: 973-972-2500 Fax: 973-972-2510 | |
Dr. Hoi-wing Susanna Yim, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 111 Central Ave, Newark, NJ 07102 Phone: 973-877-5000 | |
Tharakeswari Selvakumar, MD, PHD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 150 Bergen St # Uhi-248, Newark, NJ 07103 Phone: 973-972-6056 | |
Dr. Epifania Lopez Ramirez, M.D. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 1119 Broad St, Newark, NJ 07114 Phone: 973-824-8226 Fax: 973-824-0193 |